Navigation Links
LANL to certify automated influenza surveillance system
Date:1/31/2011

nd.

Global surveillance of pathogens such as influenza is a very important approach to combating the pandemic spread of disease. According to the World Health Organization, annual epidemics cause approximately 5 million cases of severe illness, with 250,000 to 500,000 cases leading to death. In the United States alone, the Centers for Disease Control and Prevention reports that the flu causes more than 200,000 hospitalizations and 36,000 deaths each year, with medical costs estimated at $10 billion.

Scientists, programmers, and engineers from LANL and the UCLA School of Public Health have been developing an HTLN to address global influenza surveillance. The initial prototype module underwent testing at Los Alamos in June 2009. Since then, the research team has designed high-speed and high-volume laboratory capabilities for extensive surveillance, and rapid, accurate detection and analysis of pathogens.

The automated workflow consists of field and epidemiological data surveillance, sample transportation, laboratory testing, data management, and analysis. The first node of the HTLN is housed in the Biosafety Level 3-enhanced facility of the Global Bio Lab at UCLA, which is designed to work with highly pathogenic avian influenza viruses and other potential select agents. The HTLN's novel approach to influenza surveillance will enable sequencing of as many as 10,000 full virus genomes per year, more than the total of all full influenza genomes sequenced to date.

"The HTLN project provides an opportunity to deploy high-throughput technology in a way that can protect the health of so many people," said Tracy Erkkila, LANL project manager. "We are looking forward to working with the talented team at HighRes Biosolutions to develop this important component of the HTLN project."

"A project like the HTLN requires innovative approaches to laboratory automation that provides for growth and the flexibility to leverage technological ad
'/>"/>

Contact: James E. Rickman
jamesr@lanl.gov
505-665-9203
DOE/Los Alamos National Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Carnegie Mellon developing automated systems to enable precision farming of apples, oranges
2. EMBL scientists develop first fully automated pipeline for multiprotein complex production
3. Frost & Sullivan Recognizes MIRTEC With the 2009 Award for Automated Optical Inspection Product Innovation of the Year
4. Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems
5. Genetic evidence for avian influenza movement from Asia to North America via wild birds
6. K-State researcher finds 1918 flu resulted in current lineage of H1N1 swine influenza viruses
7. SRI International to screen drugs that fight 2009 H1N1 influenza A
8. The challenges of avian influenza virus: Mechanism, epidemiology and control
9. Rapid approach to identify influenza A virus mutations and drug resistance developed
10. Early results: In children, 2009 H1N1 influenza vaccine works like seasonal flu vaccine
11. Scientists discover influenzas Achilles heel: Antioxidants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... Cholinergic inhibitors and N-methyl-D-aspartate receptor antagonists can ... fail to affect irreversible cognitive dysfunction and ... brain. Amyloid beta peptide (Aβ) vaccines reduced ... disease (AD) transgenic mouse model, and significantly ... Cao and his team, First Affiliated Hospital ...
(Date:7/9/2014)... copy of its DNA, a fundamental step in the life ... in the human body. While scientists have had an idea ... enzymes that unzip the double-stranded DNA and create "daughter" copiesthey ... works. , Now, researchers at Rockefeller University have built the ... "replication fork"the point where DNA is split down the middle ...
(Date:7/8/2014)... is an increased risk of severe perineal tearing during childbirth ... delivery, suggests a new study published today (9 July) in ... (BJOG). , This study, investigates among women who have had ... delivery in subsequent pregnancies and the recurrence of severe perineal ... childbirth and in some women the tear may be more ...
Breaking Biology News(10 mins):Rockefeller scientists first to reconstitute the DNA 'replication fork' 2Rockefeller scientists first to reconstitute the DNA 'replication fork' 3Rockefeller scientists first to reconstitute the DNA 'replication fork' 4Mode of delivery following a perineal tear and recurrence rate in subsequent pregnancies 2
... carry out one of the most remarkable forms of feeding ... extending its stomach out of its mouth and over the ... The prey tissue is partially digested externally before the soup-like ... , The researchers at Queen Mary, University of London and ...
... of breast cancer, termed estrogen receptor positive or ER+, ... each year. Research by scientists at the HudsonAlpha ... Birmingham Comprehensive Cancer Center aims to provide physicians a ... "Can we find something in the genome that correlates ...
... shape based on environment, fending off attackers or ... worked toward mimicking similar biological responses in non-living ... the medical arena. Now, researchers at ... biomimetic response using hydrogelsa material that constitutes most ...
Cached Biology News:Scientists uncover secrets of starfish's bizarre feeding mechanism 2HudsonAlpha and UAB researchers work to identify optimal treatments for ER+ breast cancer 2Light that moves and molds gels 2
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. ... Road, Warrington, Pa. , Details: The Hepatitis B ... a cure for hepatitis B and improving the quality of ... Ball on Friday, April 11 at Warrington Country Club in ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... China, Feb. 12 /PRNewswire-Asia-FirstCall/ -- Genesis,Pharmaceuticals Enterprises, Inc. (OTC ... company with its principal operations,in the People,s Republic of ... call at 9:00 a.m. Eastern on Tuesday, February 17, ... December 31, 2008 of,its fiscal year 2009. , ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), ... http://www.cordblood-america.com ) focused on bringing the life saving potential ... pleased to announce that between January 1, 2009, and ... approximately $1 million.The Company previously said in press releases ...
... (NYSE Alternext US: PTN) will announce its second quarter, ... 2009 before the open of the U.S. financial markets.Palatin ... webcast hosted by its executive management team on February ... of operations in greater detail and an update on ...
Cached Biology Technology:Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009 2Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009 3Cord Blood Announces $1 Million Reduction in Long Term Debt 2Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009 2
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
...
All-in-one mix, removes primers and dNTPs from PCR product for following direct sequencing...
Biology Products: